PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE 2026 FETCH KANSAS CITY VETERINARY CONFERENCE IN KANSAS CITY, MISSOURI

PetVivo Holdings, Inc. (OTCQX:PETV)

MINNEAPOLIS, MN, UNITED STATES, August 18, 2026 /EINPresswire.com/ — PetVivo Holdings, Inc. (OTCQX: PETV) (“PetVivo”), an emerging biomedical medical device company focused on the commercialization of innovative medical devices and therapeutics for equine and companion animals, announced today that it will exhibit at the 2026 Fetch Kansas City Veterinary Conference (“Fetch”), to be held August 28–30, 2026, at the Kansas City Convention Center in Kansas City, Missouri.

At the conference, PetVivo intends to showcase SPRYNG^® with OsteoCushion^® Technology, an intra-articular injectable veterinary medical device consisting of sterilized extracellular matrix microparticles. The microparticles are designed to adsorb onto the synovial lining of the joint and subsequently integrate with the animal’s subsynovial tissue. This action is intended to support the restoration of proper joint mechanics and aid in the management of noninfectious sources of joint pain, including joint instability, degenerative joint disease and osteoarthritis.

“Fetch Kansas City brings together veterinary professionals who are actively seeking new approaches to improve the care and quality of life of their patients,” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “We look forward to engaging directly with practitioners, sharing the growing clinical experience with Spryng and discussing how its unique OsteoCushion Technology can provide veterinarians with an additional option for managing osteoarthritis and other causes of joint-related pain. Conferences such as Fetch are an important part of our strategy to build awareness, strengthen relationships within the veterinary community and support the continued adoption of Spryng.”

For more information about PetVivo Holdings, Inc. please contact info1@petvivo.com or visit https://petvivo.com/, https://www.petvivoanimalhealth.com/ and https://www.sprynghealth.com.

Conference Details:
2026 Fetch Kansas City Veterinary Conference Exhibit Details:
Dates:
Friday, August 28, 2026, 10:15am – 6:30pm
Saturday, August 29, 2026, 10:15am – 4:45pm
Sunday, August 30, 2026, 8:00am – 11:00pm
Booth #: 916
Location: Kansas City Convention Center in Kansas City, Missouri

About PetVivo Holdings, Inc.
PetVivo Holdings, Inc. (OTCQX: PETV), in cooperation with its wholly-owned subsidiaries PetVivo Animal Health, Inc., Cosmeta Corp, and PetVivo AI, Inc., is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for equine and companion animals. The Company’s strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.

PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twelve patents and six trade secrets protect the Company’s biomaterials, products, production processes and methods of use. The Company’s lead product, SPRYNG^® with OsteoCushion^® technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint-related afflictions, including osteoarthritis, in cats, dogs and horses, is currently available for commercial sale.

Company Contact
John Lai, CEO
PetVivo Holdings, Inc.
Tel (952) 405-6216

Forward-Looking Statements
The foregoing information regarding PetVivo Holdings, Inc. (the “Company”) may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2026 and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

John Lai
Petvivo Holdings, Inc.
email us here
Visit us on social media:
LinkedIn
Facebook
YouTube

Media gallery